- Oops!Something went wrong.Please try again later.
DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Monday reported a loss of $7.8 million in its fourth quarter.
The Devon, Pennsylvania-based company said it had a loss of 44 cents per share.
The specialty pharmaceutical company posted revenue of $86,000 in the period.
For the year, the company reported that its loss widened to $39.9 million, or $2.61 per share. Revenue was reported as $86,000.
The company's shares closed at $4.78. A year ago, they were trading at $9.14.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZYNE at https://www.zacks.com/ap/ZYNE